An Verrijken

An Verrijken

Auto-generated profile, based on publicly available information

An Verrijken

Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, B-2650, Edegem, Belgium; University of Antwerp, Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP), Wilrijk, Belgium

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Journal of Hepatology
Verified
Journal Article
Open access
MNMaxime Nachit
Maxime Nachit
WKWilhelmus J. Kwanten
Wilhelmus J. Kwanten
JTJean-Paul Thissen
Jean-Paul Thissen
BBBart Op De Beeck
Bart Op De Beeck
LGLuc Van Gaal
Luc Van Gaal
ILIsabelle A. Leclercq
Isabelle A. Leclercq
To evaluate the association between muscle mass and fatty infiltration and biopsy-assessed NAFLD in patients with obesity. At inclusion (n=184) and 12 months after a dietary intervention (n=15) or a bariatric surgery (n=24), we evaluated NAFLD with liver biopsy, skeletal muscle mass index with computed tomography (CT-SMI) and bioelectrical impedance analysis (BIA-SMI). We developed an index to evaluate absolute fat content in muscle (skeletal muscle fat index; SMFI) from CT-based psoas muscle density (SMFIPsoas). Muscle mass was higher in patients with NAFLD than in those without (CT-SMI 56.8±9.9 vs 47.4±6.5 cm2/m,2 p<0.0001). There was no association between sarcopenia and NASH. SMFIPsoas was higher in NASH ≥F2 and early NASH F0-1 than in NAFL (78.5±23.6 and 73.1±15.6 vs 61.2±12.6, p<0.001). One point in score for any of the individual cardinal NASH features (i.e. steatosis, inflammation or ballooning) associated with an increase in SMFIPsoas (all p<0.05). The association between SMFIPsoas and NASH was highly significant even after adjustment for multiple confounders (all p<0.025). After intervention (n=39), NASH improvement, defined by NAS <3 or 2-point NAS score reduction, was achieved in more than 75% of patients (n=25 or n=27, respectively) that had pre-established NASH at inclusion (n=32) and associated with a significant decrease in SMFIPsoas (p<0.001). Strikingly, all patients who had ≥11% reduction in SMFIPsoas achieved NASH improvement (14/14, p<0.05). Muscle fat content, but not muscle mass, is strongly and independently associated with NASH. All individuals who achieved a ≥11% decrease in SMFIPsoas after intervention improved their NASH. These data call to explore muscle fatty infiltration as a potential marker for (and perhaps a pathophysiological contributor to) NASH. The fat content in skeletal muscles is highly reflective of the severity of non-alcoholic fatty liver disease (NAFLD) in patients with morbid obesity. In particular, muscle fat content is strongly associated with non-alcoholic steatohepatitis (NASH) and decreases upon NASH improvement. These data call to explore muscle fatty infiltration as a potential marker and perhaps a pathophysiological contributor to NASH.

23 May 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
FLFanny Lalloyer
Fanny Lalloyer
DMDenis A. Mogilenko
Denis A. Mogilenko
AVAnn Verrijken
Ann Verrijken
JHJoel T. Haas
Joel T. Haas
ALAntonin Lamazière
Antonin Lamazière
BSBart Staels
Bart Staels

1 June 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
Patrick R.M. LauwersPatrick R.M. Lauwers
Patrick R.M. Lauwers
JHJeroen M.H. Hendriks
Jeroen M.H. Hendriks
SBSaskia Van Bouwel
Saskia Van Bouwel
AVAn Verrijken
An Verrijken
KDKristof Van Dessel
Kristof Van Dessel
EDEveline Dirinck
Eveline Dirinck

2 January 2024 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
KDKristof Van Dessel
Kristof Van Dessel
AVAn Verrijken
An Verrijken
Christophe De BlockChristophe De Block
Christophe De Block
AVAnn Verhaegen
Ann Verhaegen
FPFrida Peiffer
Frida Peiffer
EDEveline Dirinck
Eveline Dirinck

28 April 2009 in Endocrine
Verified
Journal Article
Closed access
PDF file
APArmand Peeters
Armand Peeters
SBSigri Beckers
Sigri Beckers
AVAn Verrijken
An Verrijken
IMIlse Mertens
Ilse Mertens
LGLuc Van Gaal
Luc Van Gaal
WHWim Van Hul
Wim Van Hul

15 May 2021 in Endocrine Abstracts
Verified
Journal Article
Closed access
CHCarlien De Herdt
Carlien De Herdt
Christophe De BlockChristophe De Block
Christophe De Block
VKVan Dessel Kristof
Van Dessel Kristof
VAVerrijken An
Verrijken An
SFSven M Francque
Sven M Francque
EDEveline Dirinck
Eveline Dirinck
Background and aims Low levels of testosterone and non-alcoholic fatty liver disease (NAFLD) in obese men are both linked to the metabolic syndrome, but the independent association between testosterone and NAFLD needs to be elucidated. In this cross-sectional analysis the association between total testosterone (total T) and calculated free testosterone (cFT) on the one hand and NAFLD, non-alcoholic steatohepatitis (NASH) and fibrosis on the other hand was investigated in obese men. Methods Data of 134 men of 18 years or older and a body mass index of at least 25 kg/m2 who underwent a liver biopsy after visiting the obesity clinic were collected. Liver biopsy was performed if there was suspicion of NAFLD. Individuals were classified into 4 categories: no NAFLD, NAFL, NASH (no fibrosis (F0) or F1) or NASH with advanced fibrosis (F2-F4). Because of an unequal distribution of fibrosis, the 5 stages were regrouped into F0–1 and F2–4. Results Mean age was 45 ± 12, median BMI was 39.6 kg/m2 (range 25.0–64.9). Only 5.2% of the individuals had no NAFLD. Of the individuals with NAFLD, 15.7% had NAFL, 56.7% had NASH F0-F1 and 22.4% had NASH F2-F4. Fibrosis stage 0 to 4 were present in respectively 47.8, 26.9, 17.2, 7.5 and 0.7%. cFT and total T were below the limit of normal in respectively 63% and 23% of individuals. One-way ANOVA showed a tendency toward a difference in the level of cFT between the grades of NAFLD (P = 0.053) that did not persist after controlling for confounding variables. No significant difference was seen for total T. Ordinal regression analysis showed a decreasing level of cFT was associated with an increase in the grade of NAFLD (P = 0.005) that did not persist after controlling for confounding variables. No significant effect of total T on the grade of NAFLD was seen. When performing the same analyses for fibrosis and after controlling for confounding variables, no difference in the level of cFT or total T were seen between F0-F1 and F2-F4 and no effect of cFT or total T was seen on the stage of fibrosis. Conclusion To the best of our knowledge, this is until now the largest study investigating the association between sex steroid levels and biopsy-proven NAFLD. After controlling for confounding variables no association was found between the level of total T and cFT on the one hand and NAFLD, NASH or fibrosis on the other hand.